Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA staff review raises questions about MannKind diabetes device
FDA staff review raises questions about MannKind diabetes device
FDA staff review raises questions about MannKind diabetes device
Submitted by
admin
on March 29, 2014 - 9:13am
Source:
Yahoo/Reuters
News Tags:
MannKind
diabetes
type 2 diabetes
Headline:
FDA staff review raises questions about MannKind diabetes device
Do Not Allow Advertisers to Use My Personal information
